> Researchers at the University of North Carolina at Chapel Hill are working with two pharmaceutical companies to translate their dengue virus breakthrough into a vaccine. Item
> Certain genetic mutations identified by researchers at the Broad Institute and Massachusetts General Hospital can reduce the risk of developing Type 2 diabetes, even in people who have risk factors such as obesity and old age. More
> Low-level exposure to bisphenol A appears to cause fetal abnormalities in primates. Story
> Ohio State University scientists have identified a potential drug target for brain cancer. Release
> TeraDiscoveries has partnered with Egenix to design new drugs for cancer and autism. TeraDiscoveries will use its software platform to design new drug molecules to help Egenix accelerate its drug discovery and development process. Release
Editor's Note: In last week's issue of FierceBiotechResearch, a story on VentriNova mis-stated the company's origins. It was spun out of Columbia University.